Park, "Human disease associated with Clostridium perfringens enterotoxin," Reviews of Environmental Contamination and Toxicology, vol.
Anderson, "Structure of the claudin-binding domain of Clostridium perfringens enterotoxin," The Journal of Biological Chemistry, vol.
Regulated expression of
Clostridium perfringens enterotoxin in naturally cpe-negative Type A, B, and C isolates of C.
Inactivation of the gene (cpe) encoding
Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C.
Similar frequency of detection of
Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated diarrhea.
Evaluation of two techniques for detecting
Clostridium perfringens enterotoxin in faecal samples.
Clostridium perfringens enterotoxin was detected in stool samples collected from six ill inmates, and 43,000 CFU/g of the organism were isolated from a remaining sample of casserole.
The presence of
Clostridium perfringens enterotoxin (CPE) was determined either by assaying the cytopathic effect on Vero cells or by reverse passive latex agglutination (RPLA) test (Oxoid Italia Spa, Garbagnate Milanese, Milan) according to the manufacturer's instructions (14).
Nucleotide sequencing and expression of the
Clostridium perfringens enterotoxin gene in Escherichia coli.
Production and characterization of monoclonal antibodies to
Clostridium perfringens Enterotoxin. Infection and Immunity, v.52, n.1, p.31-35, 1985.
